|
|
Volumn 7, Issue 3, 1996, Pages 401-416
|
|
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: A pilot trial
a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
CARMUSTINE;
CD34 ANTIGEN;
COMPLEMENTARY DNA;
CYCLOPHOSPHAMIDE;
ETOPOSIDE;
GRANULOCYTE COLONY STIMULATING FACTOR;
INTERLEUKIN 3;
INTERLEUKIN 6;
MESNA;
MESSENGER RNA;
PACLITAXEL;
THIOTEPA;
ADULT;
ALOPECIA;
AMENORRHEA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
BLOOD TOXICITY;
BONE MARROW SUPPRESSION;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CELL PROLIFERATION;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG HYPERSENSITIVITY;
DRUG RESISTANCE;
FEMALE;
GENE TRANSFER;
HEART DISEASE;
HEMATOPOIETIC CELL;
HEMORRHAGIC CYSTITIS;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
NAUSEA;
NEUROLOGIC DISEASE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RETROVIRUS;
STATISTICAL ANALYSIS;
STEM CELL TRANSPLANTATION;
SUBCUTANEOUS DRUG ADMINISTRATION;
TREATMENT PLANNING;
VIRUS RECOMBINANT;
VOMITING;
ANIMALIA;
UNIDENTIFIED RETROVIRUS;
|
|
EID: 0030021116
PISSN: 10430342
EISSN: None
Source Type: Journal
DOI: 10.1089/hum.1996.7.3-401 Document Type: Article |
|
Times cited : (31)
|
|
References (0)
|